Field Melvin, Jungreis Charles A, Chengelis Nicole, Kromer Holly, Kirby Lori, Yonas Howard
Department of Neurological Surgery, University of Pittsburgh School of Medicine, PUH Suite B-400, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
AJNR Am J Neuroradiol. 2003 Jun-Jul;24(6):1200-7.
Therapeutic internal carotid artery (ICA) occlusion for symptomatic intracavernous artery aneurysms can result in ischemic infarction despite normal clinical balloon test occlusion (BTO). We evaluated outcomes in patients with symptomatic cavernous sinus aneurysms in whom clinical BTO was normal, who underwent carotid occlusion with selective bypass surgery guided by physiologic BTO using quantitative cerebral blood flow (CBF) analysis by means of stable xenon-enhanced CT.
After a normal clinical BTO, 26 consecutive patients with symptomatic cavernous sinus aneurysms underwent a baseline xenon-enhanced CT CBF analysis followed by a second CBF analysis, during which repeat BTO was performed. Patients with a decrease in cortical CBF to below 30 mL/100 g/min were considered moderate risk and those with greater than 30 mL/100 g/min were low risk for developing postocclusion ischemic infarction. Moderate-risk patients underwent cerebral revascularization followed by proximal carotid occlusion. Low-risk patients underwent carotid occlusion alone. Patients were clinically followed up for at least 3 months after carotid occlusion. All patients underwent head CT at least 1 month after carotid occlusion.
Eight patients were moderate risk and 18 low risk. Mean follow-up was 15.3 months. Mean CT follow-up was 10.2 months. No low-risk patient developed a postocclusion ischemic deficit by examination or infarct by CT. One patient in the moderate-risk group developed right hemiparesis and a left posterior middle cerebral artery infarction by CT 2 months after carotid occlusion.
In this series, BTO combined with quantitative CBF analysis was a safe and reliable technique for identification of patients at risk for ischemic infarction after carotid occlusion, despite a normal clinical BTO.
对于有症状的海绵窦内动脉瘤,尽管临床球囊试验闭塞(BTO)结果正常,但治疗性颈内动脉(ICA)闭塞仍可能导致缺血性梗死。我们评估了有症状的海绵窦动脉瘤患者的预后,这些患者临床BTO结果正常,在生理性BTO引导下采用稳定氙增强CT定量脑血流量(CBF)分析进行选择性搭桥手术并接受颈动脉闭塞。
在临床BTO结果正常后,26例连续的有症状海绵窦动脉瘤患者先进行一次基线氙增强CT CBF分析,随后进行第二次CBF分析,期间重复进行BTO。皮质CBF降至30 mL/100 g/min以下的患者被视为中度风险,而高于30 mL/100 g/min的患者发生闭塞后缺血性梗死的风险较低。中度风险患者先进行脑血管重建,然后进行颈动脉近端闭塞。低风险患者仅接受颈动脉闭塞。颈动脉闭塞后对患者进行至少3个月的临床随访。所有患者在颈动脉闭塞后至少1个月进行头部CT检查。
8例患者为中度风险,18例为低风险。平均随访时间为15.3个月。CT平均随访时间为10.2个月。通过检查,没有低风险患者出现闭塞后缺血性缺陷,CT检查也未发现梗死。中度风险组中有1例患者在颈动脉闭塞后2个月出现右侧偏瘫,CT显示左侧大脑中动脉后支梗死。
在本系列研究中,尽管临床BTO结果正常,但BTO联合定量CBF分析是一种安全可靠的技术,可用于识别颈动脉闭塞后有缺血性梗死风险的患者。